FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to the field of chemistry and the chemical and pharmaceutical industry, namely to a method for producing substance of miglustat of ((2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol), which includes the interaction of 2,3,4,6-tetra-O-benzyl-D-glucopyranose with sodium borohydride in a mixture of dichloromethane and methanol, to obtain 2,3,4,6-Tetra-O-benzyl-D-glucitol, which is extracted with ethyl acetate and, after drying and evaporation of an organic layer, purified from traces of water by azeotropic distillation with toluene; sequential oxidation of 2,3,4,6-Tetra-O-benzyl-D-glucitol with a mixture of dimethyl sulfoxide (DMSO) and phosphorus oxide P2O5 to form a 1,5-dicarbonyl derivative, purification of the specified derivative with diethyl ether and its reductive amination using sodium cyanoborohydride; purification by recrystallization from methanol obtained by the amination reaction of 2,3,4,6-Tetra-O-benzyl-N-butyl-1,5-dideoxy-1,5-D-glucitol; its interaction with hydrogen in the presence of palladium as a catalyst, deposited on activated carbon at a hydrogen pressure equal to one atmosphere, to form (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol with subsequent purification of the target product with silica gel.
EFFECT: high yield of stable miglustat substance.
1 cl, 10 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PIPERIDINE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2279425C2 |
MIGLUSTAT N-BUTYL-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL | 2019 |
|
RU2743694C1 |
NEW GLUCITOL DERIVATIVE, PRODRUG AND SALT AND THERAPEUTIC AGENT CONTAINING THEM FOR DIABETES TREATMENT | 2005 |
|
RU2386631C2 |
SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
β-LACTAMS, METHOD FOR PREPARING INDICATED COMPOUNDS AND SERUM HYPOCHOLESTEROLEMIC AGENTS CONTAINING SUCH COMPOUNDS | 2002 |
|
RU2301799C2 |
COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
C-GLYCOSIDE DERIVATIVES CONTAINING A CONDENSED PHENYL RING, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF PRODUCING SUCH AND A PHARMACEUTICAL COMPOSITION CONTAINING SUCH | 2017 |
|
RU2739024C2 |
NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
METHOD FOR PRODUCING DEPHENYLMETHANE DERIVATIVE | 2017 |
|
RU2797392C2 |
METHOD OF PRODUCING DEPHENYLMETHANE DERIVATIVE | 2023 |
|
RU2814846C1 |
Authors
Dates
2021-12-21—Published
2020-12-28—Filed